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Michal Caspi†, Gili Perry†, Nir Skalka, Shilhav Meisel, Anastasia Firsow, Maayan Amit and Rina Rosin-Arbesfeld*Abstract
The Wnt signaling pathway is an evolutionary conserved system, having pivotal roles during animal development.
When over-activated, this signaling pathway is involved in cancer initiation and progression. The canonical Wnt
pathway regulates the stability of β-catenin primarily by a destruction complex containing a number of different
proteins, including Glycogen synthase kinase 3β (GSK-3β) and Axin, that promote proteasomal degradation of
β-catenin. As this signaling cascade is modified by various proteins, novel screens aimed at identifying new Wnt
signaling regulators were conducted in our laboratory. One of the different genes that were identified as Wnt
signaling activators was Aldolase C (ALDOC). Here we report that ALDOC, Aldolase A (ALDOA) and Aldolase B
(ALDOB) activate Wnt signaling in a GSK-3β-dependent mechanism, by disrupting the GSK-3β-Axin interaction
and targeting Axin to the dishevelled (Dvl)-induced signalosomes that positively regulate the Wnt pathway thus
placing the Aldolase proteins as novel Wnt signaling regulators.
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One of the fundamental tasks of a cell in order to con-
trol its fate and the function of the entire organism is
to create dynamic systems of signaling pathways. Today,
it is well accepted that a few signaling pathways control
the major developmental processes. When aberrantly
regulated theses pathways lead to devastating diseases
ranging from neurological diseases to cancer. One such
pathway, which when up-regulated is implicated in a
growing list of degenerative diseases and in most cases
of colorectal cancer (CRC) is the Wnt signaling pathway
[1]. In un-stimulated cell, the Wnt signaling cascade is
silenced due to the activity of a dedicated cytoplasmic
destruction complex that phosphorylates β-catenin, the
key effector of the canonical Wnt pathway, marking it
for ubiquitination, and subsequent degradation. This
destruction complex consists of the scaffold protein
Axin, the tumor suppressor adenomatous polyposis coli
(APC) and the kinases glycogen synthase kinase-3
(GSK-3) α/β and casein kinase-1α (CKIα) [2,3]. The Wnt
signaling cascade initiates with binding of the Wnt ligand* Correspondence: arina@post.tau.ac.il
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unless otherwise stated.to its receptor frizzled (Fz) and co-receptor low-density
lipoprotein receptor-related protein 5/6 (LRP5/6). This
event ultimately leads to accumulation and nuclear
translocation of β-catenin resulting in expression of
Wnt target genes [4]. Still, the mechanism of the Wnt
signal transmission remains incompletely understood.
According to the current model, the activated Wnt recep-
tors recruit dishevelled (Dvl) to the plasma membrane. In
turn, Dvl along with other Wnt signaling regulators such
as LRP induce the formation of “puncta-like” structures
classified as LRP-signalosomes [5]. In the signalosomes
LRP is phosphorylated resulting in inhibition of GSK-3β
which leads to the “β-catenin destruction complex” in-
activation and accumulation of β-catenin. However this
model is still being challenged and new Wnt signaling
components and mechanisms of action are frequently
being described. In an attempt to identify new Wnt
signaling components we utilized a novel screening
technique based on expression of an episomal cDNA
library in mammalian cells followed by selection of
clones that survive only in the continuous presence of
Wnt stimulus [6]. One of the genes that were isolated in
three separate experiments was Aldolase C fructose bispho-
sphate (ALDOC) the fourth enzyme of glycolysis, which
catalyzes reversible cleavage of fructose 1,6-bisphosphatetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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phosphate [7]. In vertebrates, the Aldolase family consists
of three isozymes that are structurally very similar: Aldol-
ase A (ALDOA), the muscle and red blood cells isoform;
Aldolase B (ALDOB), the liver, kidney and intestine
isoform; and ALDOC, the brain and nervous system
isoform [8,9]. Although the role of Aldolase in metabolism
is well established, there is growing evidence for many
alternative functions for this enzyme. In particular,
Aldolase interacts with various proteins unrelated to
glycolytic enzymes, including cytoskeleton proteins such
as F-actin [10,11], WASP [12] and tubulin [13]. Aldolase
also interacts with other types of proteins such as proteins
involved in vesicle and intracellular trafficking [14-16]
proton pumps [16,17] and is crucial for proliferation of
cancer cells through a non-glycolytic pathway [18].
In the present study we show that Aldolase activates
Wnt signaling by forming a complex with GSK-3β that
disrupts the GSK-3β-Axin interaction leading to mem-
brane translocation of Axin. These findings indicate that
Aldolase isomers can function as novel regulators of the
canonical, oncogenic Wnt signaling pathway and may
become new anti-cancer therapeutic targets.
Materials and methods
Cell culture and transfection
Human embryonic kidney 293T (HEK293T), human
cervical cancer (HeLa), monkey kidney (COS-7) and
the human colon carcinoma SW480 cell lines were
maintained in Dulbecco’s modified Eagle’s medium
(GIBCO) supplemented with 10% fetal bovine serum
and 100 units/ml penicillin/streptomycin (Beit-Haemek).
Cells were cultured at 37°C in a humidified incubator with
5% CO2. For HEK293T cells, transfections were carried
out using the standard CaPO4 precipitation method,
or using Polyethylenimine (PEI) reagent (Polysciences)
following manufacturer’s guidelines. For HeLa, COS-7 and
SW480 cells, Polyethylenimine (PEI) reagent (Polysciences)
was used. SB (SB-216763) is a small molecule that com-
petes with ATP and potently inhibits the activity of GSK-3β
was used (Sigma, Israel; 10 μM; 4 hours).
Plasmids
GFP-ALDOB expression vector was constructed by insert-
ing ALDOB cDNA (provided by Marçal Pastor-Anglada,
Universitat de Barcelona, Barcelona, Spain) into pEGFP-
C2 (Clontech, Palo Alto, CA) using EcoRI and SalI restric-
tion sites. GFP-ALDOC was constructed in our laboratory
by amplifying ALDOC cDNA by PCR (using the primers
5′-AGAGGGATCCGCAT GCCTCACTCGTACCCAGC
C-3′ and 5′- AGAGCTCGAGGTAGGCATGGTTG GC
AATGTAGAG-3′) and subcloning into pEGFP-C2 using
BglII and SalI restriction sites. The ORF of human Aldol-
ase A was cloned into pEGFP-C2 vector using EcoRI andKpnI sites. For PCR we used the primers: EcoRI-AldA-
Fw- AAAAGAATTCATGCCCTACCAATATCCAGC, and
KpnI-AldA-Rv-AAAGGTACCATAGGCGTGGTTAGAG
ACGAAG. HA-GSK-3β and FLAG–GSK-3β expression
vectors were kindly provided by T.C. Dale (Developmental
Biology, Chester Beatty Laboratories, Institute of Cancer
Research, London, UK) and Hagit Eldar-Finkelman (Tel-
Aviv University, Tel-Aviv, Israel), respectively. GFP-Axin
and FLAG-Axin expression vectors were kindly provided
by Mariann Bienz (MRC Laboratory of Molecular Biology,
Hills Road, Cambridge, UK) and T.C. Dale, respectively,
and were described previously. The Wnt-responsive
TCF-dependent luciferase constructs pTOPFLASH and
its mutated version pFOPFLASH were kindly provided
by H. Clevers (Center for Biomedical Genetics, Utrecht,
Netherlands) and were described before. pSV-β-Galactosi-
dase Control Vector and pCMV-Renilla were purchased
from Promega (Madison, WI).
Luciferase reporter assay
Twenty four hours after seeding in 24-well plates at
1×105 cells per well, cells were transfected with relevant
DNA plasmids, along with pGL3-OT (pTOPFLASH) or
pGL3-OF (pFOPFLASH) – luciferase reporter constructs.
These constructs contain the firefly luciferase open
reading frame under the control of three copies of
either wild-type (pTOPFLASH) or mutated TCF binding
element (pFOPFLASH) [19]. These constructs are used
for assessing changes in the canonical Wnt pathway.
The β-galactosidase construct (in HEK293T cells) or
CMV-Renilla (in SW480 cells) were used to monitor
transfection efficiency. Forty eight hours post-transfection,
cells were washed with phosphate-buffered saline (PBS)
and harvested on ice using Reporter Lysis Buffer (Promega).
Cell lysates were centrifuged for 15 minutes at 14,000 rpm
at 4°C and their luciferase activity was measured following
manufacturer’s instructions. Specificity of luciferase activity
was validated using the pFOPFLASH plasmid. Residues
of supernatants were analyzed by Western blotting as
described below.
Western blot analysis and immunoprecipitation
HEK293T cells were transfected as indicated above, and
48 hours later washed with PBS and harvested on ice
using lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl,
1% Triton), or radioimmunoprecipitation assay (RIPA)
buffer (50 mM Tris-HCl pH 7.4, 1% NP-40, 0.25% sodium
deoxycholate, 150 mM NaCl, 1 mM EDTA) supplemented
with 1% protease inhibitor cocktail (Sigma). Cell lysates
were centrifuged for 15 minutes at 10,000-14,000 rpm
at 4°C. Supernatants were separated on 7.5% or 10%
SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and
proteins were transferred to nitrocellulose membranes.
After blocking with 5% low fat milk, membranes were
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with 0.001% tween-20 in PBS, incubated for 60 minutes
with secondary antibodies, washed again three times and
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Figure 2 Aldolase activation of the Wnt pathway depends on
the “β-catenin degradation complex”. (A) SW480 cells were
co-transfected with the following plasmids: GFP-ALDOC, GFP-ALDOB
or an empty vector, pTOPFLASH or pFOPFLASH and Renilla. Forty
eight hours later, cells were harvested and lysates were measured
for their luciferase activity, (upper panel) and levels of endogenous
active β-catenin by western blot (lower panel). Tubulin served as a
loading control. Data presented describe relative mean values and
standard deviations of four independent experiments performed in
duplicates or triplicates. (B) HEK293T cells were transfected with GFP,
GFP-β-catenin, GFP-ALDOC or the GFP-ALDOB constructs as indicated,
along with the pTOPFLASH or pFOPFLASH and β-gal plasmids.
Luciferase assay (upper panel) and western blot analysis (lower
panel) were performed as described.
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at 4°C. Alternatively, cell lysates were incubated with the
specific antibody for two hours on ice prior to two hours
rotated incubation with protein A/G agarose (Santa Cruz
Biotechnology) at 4°C. Following incubation, beads were
collected by slow centrifugation, washed four times with
lysis buffer and analyzed by Western blotting as described.
For endogenic IP assays, mouse brain extracts were
homogenized in RIPA buffer supplemented with 1%
protease inhibitor cocktail. Following centrifugation,
supernatants were incubated for two hours on ice with
the relevant antibody or with control unimmuned
serum, and then incubated at 4°C with rotation with
protein A/G agarose and separated by SDS-PAGE as
designated before. The following antibodies were used
(for immunoblotting, unless mentioned otherwise): goat
anti-Aldolase B (1:500; Santa Cruz Biotechnology), goat
anti-Aldolase C (1:500; Santa Cruz Biotechnology), goat
anti-Axin (1:250 for IP; Santa Cruz Biotechnology), rabbit
anti-SOX-9 (1:500; Millipore) rabbit anti-GFP (1:1000;
Santa Cruz Biotechnology), mouse anti-GFP (1:1000;
Abcam), mouse anti-GSK-3β (1:5000; BD Transduction
Laboratories), rat anti-HA (1:5000; Roche), mouse anti-
FLAG (1:5000; Sigma), mouse anti-β-catenin (1:100; BD
Transduction Laboratories), mouse anti-β-catenin active
(1:1000; Millipore), rabbit anti-phospho-β-catenin (1:1000;
cell signaling), and mouse anti-Tubulin (1:10,000; Sigma),
anti-Striatin (1:1000; BD Transduction Laboratories),
Rabbit anti-GSK-3β used for IP was kindly provided
by Hagit Eldar-Finkelman (Tel-Aviv University, Tel-Aviv,
Israel). Anti-goat horseradish peroxidase-conjugated
secondary antibody was obtained from Santa Cruz
Biotechnology and was used at a 1:5000 dilution.
Anti-mouse and anti-rabbit secondary antibodies were
obtained from Jackson Immuno Research and were
used at a 1:10,000 dilution.
Immunufluorescence
HEK293T, HeLa or COS-7 cells were seeded on glass





























































Figure 3 (See legend on next page.)
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Figure 3 GSK-3β co-localizes and interacts with Aldolase proteins. (A) HEK293T cells were co-transfected with FLAG-GSK-3β or an empty
vector, and with GFP-ALDOC (left), GFP-ALDOB (right) as indicated. Forty eight hours post transfection, cells were harvested and lysates were
co-immunoprecipitated with anti-FLAG M2 beads, separated by SDS-PAGE and visualized using the indicated antibodies. (B) HEK293T cells were
co-transfected with FLAG-GSK-3β and increasing concentrations of GFP-ALDOC (0-10 mg DNA). Forty eight hours post transfection, cells were
harvested and lysates were co-immunoprecipitated with anti-FLAG M2 beads, separated by SDS-PAGE and visualized using the indicated
antibodies. Striatin was used as a negative control to rule out non-specific interactions. (C) Mouse brain lysates were co-immunoprecipitated
with rabbit anti-GSK-3β antibody or with control un-immuned serum incubated with protein A/G beads and separated by SDS-PAGE. Blots were incubated
with anti-GSK-3β, anti-ALDOC or anti-ALDOB antibodies. (D) HEK293T cells grown on cover slips were transfected with GFP-ALDOC (upper panel) or
GFP-ALDOB (lower panel). Forty eight hours later, cells were fixed, permeabilized, and incubated with an anti-GSK-3β antibody. Cell nuclei
were then stained with DAPI, and viewed using confocal microscopy. (E) Untransfected HEK293T cells grown on cover slips were subjected to
immunofluorescence assay as in D, using the indicated antibodies. (F) HeLa cells grown on cover slips were subjected to immunofluorescence
assay as in D, using the indicated antibodies.
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were washed with PBS and fixed in PBS containing 4%
paraformaldehyde (PFA) for 20 minutes. Fixed cells
were washed twice with PBS, permeabilized with PBS
containing 0.1% Triton (PBT) for 10 minutes and
blocked in PBS containing 1% BSA and 0.1% Triton
(BBT) for one hour. Afterwards, cells were incubated at
room temperature with primary antibodies for 60 minutes,
washed three times with PBT, incubated with secondary
antibodies for 30 minutes, and washed again three times.
Finally, cell nuclei were stained with 10 μg/ml 4′,6-Diami-
dino-2-phenylindole (DAPI, Sigma) for 5 minutes. Slides
were visualized by confocal microscopy or by phase
contrast microscopy (Leica SP2, Leica Microsystems,
Bannockburn, IL).
The following antibodies were used: goat anti-Aldolase
B (1:100; Santa Cruz Biotechnology), goat anti-Aldolase
C (1:100; Santa Cruz Biotechnology), rabbit anti-FLAG
(1:400; Sigma), mouse anti-GSK-3β (1:300; BD Trans-
duction Laboratories), rat anti-HA (1:300; Roche), mouse
anti-myc (1:200; Santa Cruz Biotechnology). Anti-goat,
anti-mouse, anti-rabbit and anti-rat fluorescent anti-
bodies were obtained from Invitrogen and were used at
a 1:500 dilution.
siRNA assay
HEK293T cells were transfected with 30nM GSK siRNA
(siGENOME SMART pool M-003010-03-0005 hGSK3b
NM-002093), 50 or 100nM siGENOME ALDOC siRNA;
NM_005165; M-012697-01-0005 or non-targeting RNA
oligonucleotides as scrRNA, using DharmaFECT-1 as
transfection reagent; siRNA and scrRNA oligonucleotides,
together with the mentioned reagent, were all purchased
from Thermo Scientific Dharmacon (Essex, UK). Cells
were either harvested for western blot analysis after
72 h or transfected with the relevant DNA plasmids
after 24 h. Forty eight h later the transfectedcells were
harvested and analyzed using Western blots as described
above All animal work was conducted according to
national and international guidelines and approved by
the Tel Aviv University review board.Results
Aldolase isomers activate the canonical Wnt signaling
pathway
ALDOC was isolated in a screen aimed at identifying
new Wnt signaling activators [6]. To validate this effect,
both ALDOC and ALDOB, were tested for their ability
to activate Wnt signaling. Results show that ectopic
expression of both proteins increase Wnt/β-catenin
mediated transcription (Figure 1A, upper panel) and more
importantly led to increased levels of the endogenous
active form of β-catenin (Figure 1A, lower panel). Simi-
larly, reducing the endogenous levels of ALDOC by
specific siRNA oligonucleotides led to decreased Wnt/
β-catenin mediated transcription (Figure 1B). Activation
of the Wnt cascade ultimately results in elevated levels
of Wnt target genes. Our results show that expression
of both ALDOC and ALDOB dramatically induced the
expression of Wnt target genes such as c-myc and
SOX-9 in addition to increasing the levels of active
and total β-catenin in both HEK293T and HeLa cells
(Figure 1C; Additional file 1: Figure S1). The widely
expressed ALDOA that is highly similar to ALDOB
was also tested. Our results demonstrate that similarly
to the other ALDO isoforms, expression of ALDOA
leads to enhanced expression of active β-catenin and
activates the canonical Wnt signaling cascade (Figure 1D).
When examining the ALDO activity of our constructs
(Additional file 2) we noticed that all our ALDO isomers
have similar activity (Additional file 1: Figure S2A) although
the activity of ALDOA is known to be significantly higher
than that of the other ALDO isomers [20,21]. However, the
differences in activity between ALDOA and ALDOB are
so extensive when the activity of the purified proteins is
compared (around 6 fold). In contrast, when the ALDO
activity of crude extracts from bacteria overexpressing
ALDOB and ALDOA are measured the differences are
reduced to two folds [21]. In addition this study also
shows that although Rabbit muscle ALDOA has very
similar activity to recombinant ALDOA, the activity of
the recombinant ALDOB is much higher than that of
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Figure 4 (See legend on next page.)
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Figure 4 Aldolase requires GSK-3β for activating the Wnt pathway but does not affect the phosphorylation of β-catenin. (A) HEK293T
cells were subjected to GSK-3β depletion using siGSK-3β RNA oligonucleotides. Twenty four hours later, cells were co-transfected with GFP-ALDOC,
GFP-ALDOB or an empty vector. After additional forty eight hours, cells were harvested and separated by SDS-PAGE. Blots were incubated with
anti-active β-catenin, anti-GFP, anti-GSK-3β or anti-tubulin as indicated (upper panel). TINA analysis of active β-catenin band intensity is
presented (lower panel). (B) Untransfected or cells transfected with ALDOB or ALDOC were treated with SB (10 μM; 4 hours) as indicated.
Twenty four hours later the cells were harvested and separated by SDS-PAGE. Blots were incubated with the indicated antibodies (upper
panel). TINA analysis of active b-catenin band intensity was performed on 2 separate experiment (lower panel). (C) HEK293T or HeLa cells
were transfected with GFP-ALDOC, GFP-ALDOB or an empty vector. Forty eight hours later, cells were harvested and lysates were subjected
to western blot analysis using specific antibodies to anti-phospho-β-catenin, anti-GFP, anti-GSK-3β or anti-tubulin as indicated.
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the different ALDO isomers utilized in our current
study show similar activity due to the fact that crude
mammalian cell extracts ectopically expressing recom-
binant ALDO isomers were used.Aldolase activation of the Wnt pathway depends on an
intact “β-catenin degradation complex”
To examine whether ALDOB and ALDOC activity requires
an intact destruction complex, SW480 cells were used.
In these cells the APC protein is mutated [22] and as a
result the “β-catenin degradation complex” is not func-
tional. Results show that both ALDOB and ALDOC
had no effect on Wnt/β-catenin mediated transcription
or β-catenin protein levels in these cells (Figure 2A)
thus suggesting that the destruction complex may be
required for the activity of Aldolase.GSK-3β interacts with Aldolase proteins
Both the two GSK-3 isoforms and the three Aldolase
isozymes are metabolic enzymes. While GSK-3α/β inhibit
glycogen synthase thus preventing the conversion of
glucose to glycogen [23], the Aldolase proteins are respon-
sible for the conversion of fructose 1,6-diphosphate into
dihydroxyacetone phosphate (DHAP) and glyceraldehyde-
3-phosphate (GA3P) [7]. Thus, we examined whether
ALDOB and ALDOC interact with GSK-3β. HEK293T
cells were co-transfected with plasmids encoding for
FLAG-tagged GSK-3β and GFP-tagged ALDOB or
ALDOC. As shown in Figure 3A, GSK-3β co-immuno-
precipitated with the Aldolase proteins. Expressing
different amounts of the ALDOC proteins did not
alter the amount of the ALDOC-GSK-3β complex
(Figure 3B). Importantly, endogenous GSK-3β specific-
ally co-immunoprecipitated with both ALDOB and
ALDOC in brain extracts (Figure 3C). Examining the
subcellular localization of GSK-3β and Aldolase revealed
that both ectopically expressed and endogenous ALDOB
and ALDOC co-localize with endogenous GSK-3β in both
293T and HeLa cells (Figure 3D, E, F).Aldolase depends on GSK-3β for activating the Wnt
pathway but does not affect the phosphorylation of
β-catenin
Next we examined whether Aldolase depends on GSK-3β
for its activity in Wnt signaling. SiRNA oligonucleotides
targeting GSK-3β were used to silence endogenous
GSK-3β in HEK293T cells which, as expected, led to
increased levels of active β-catenin. Importantly, depletion
of GSK-3β hampered the ability of ALDOB and ALDOC
to elevate the β-catenin protein levels (Figure 4A) as
shown earlier (Figure 1). Similarly, inhibiting GSK-3β (and
thus elevating the levels of active β-catenin) by using SB
[24] abolished the activity of the Aldolase proteins on β-
catenin (Figure 4B). As GSK-3β phosphorylates β-catenin,
thus targeting the latter for degradation we examined
whether expression of ALDOC and ALDOB change the
phosphorylation levels of β-catenin. Results indicate that
ALDOC and ALDOB do not affect the phosphorylation
levels of β-catenin (Figure 4C).Aldolase activates Wnt signaling by disrupting the Axin-
GSK-3β interaction and targeting Axin to the Dvl “puncta”
In the absence of a Wnt signal GSK-3β phosphorylates
Axin which leads to enhanced activity of Axin and
stabilization of the cytoplasmic “β-catenin degradation
complex”. However, when the Wnt signal is activated,
the “β-catenin degradation complex” disassembles and
Axin is recruited to Dvl-induced “puncta” suggested to
function as signalosomes [5,25]. Our results show that
when over-expressed, both ALDOB and ALDOC disrupt
GSK-3β-Axin interaction thus GSK levels detected in
the complex are reduced (Figure 5A). Importantly, expres-
sion of the Aldolase proteins induce formation of large
Dvl-Axin “puncta” that are similar to those seen when the
specific GSK-3β inhibitor SB is used (Figure 5B-C).Discussion
The canonical Wnt signaling pathway regulates the sta-
bility of the β-catenin protein. In the absence of a Wnt
signal, β-catenin resides in a large cytoplasmic protein
complex where it is phosphorylated and subsequently
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ition of this β-catenin degradation complex in different
mechanisms [26], some just recently proposed [27]. To

































Figure 5 Aldolase activates Wnt signaling by disrupting the Axin-GSK
HEK293T cells were co-transfected with GFP-Axin or an empty vector, and
post transfection, cells were harvested and lysates were co- immunoprecip
and separated by SDS-PAGE. Blots were incubated with anti-GFP; anti-GSK-
and FLAG-Axin along with GFP-ALDOB, GFP-ALDOC or an empty vector. Fo
incubated with anti-FLAG and anti-myc antibodies. Cell nuclei were then st
used as a positive control for activation of the Wnt pathway (C) Stained ce
(2 for only large, 1 for large and small, 0 small or diffused distribution) 20-2have developed a novel screen aimed at identifying novel
activators of the Wnt signaling pathway [6]. One of the
genes isolated in this screen was ALDOC. Our results

























-3β interaction and targeting Axin to the Dvl “puncta”. (A)
with GFP-ALDOC, GFP-ALDOB or an empty vector. Forty eight hours
itated with goat anti-Axin antibody or with control un-immuned serum
3β or anti-tubulin (B) COS-7 cells were co-transfected with myc-Dvl
rty eight hours post transfection; cells were fixed, permeabilized and
ained with DAPI, and visualized using a confocal microscopy. SB was
lls from B were scored according to Axin distribution in large “puncta”
5 cells were scored for each condition.
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a significant increase of the endogenic signal, without
ectopic activation (such as β-catenin or other known
positive regulators of the pathway). Similarly, expression
of the Aldolase proteins induced expression of several
endogenous Wnt target genes. This may imply that
Aldolase, primarily a glycolytic enzyme, could act as a
colorectal oncogene – an assumption that correlates
with the Warburg effect describing enhanced glucose
uptake and glycolysis in cancerous cells [28]. Accordingly,
over-expression of ALDOA and ALDOC were previously
reported in various tumor types [29,30]. A recent paper
demonstrated that ALDOA is critical for proliferation
of transformed cell lines, though not by means of its
glycolytic functions [18]. Moreover, ALDOA was lately
reported as a prognostic marker of colorectal cancer
progression, highly expressed in disease stages I and IV
[31]. Nonetheless, it should be noted that ALDOB was
found to be down-regulated in the progressive stages of
hepatocellular carcinoma, probably due to transition of
the cancerous cells into utilizing alternative paths for
energy sources, for instance – ALDOA overexpression [32].
The transition of malignant tissues into over-expressing
ALDOA at the expense of the prevalent Aldolase isozyme











Figure 6 A hypothetic model for the role of the Aldolase proteins in
β-catenin is degraded by a dedicated cytoplasmic “β-catenin degradation p
proteins, Aldolase binds GSK-3β, the “β-catenin degradation protein compl
and the Wnt cascade is activated.decrease of serum ALDOB levels in malignant tissues,
including in patients with gastric cancer [33]. It is import-
ant to note that there is a de-differentiation of tissue-
specific expression to the embryonic pattern in both cancer
and cell lines and that this is the major reason that Aldolase
B and/or C give way to the embryonic Aldolase A in
mammalian cells. Given the role of GSK-3β in regulation
of carbohydrate metabolism, we hypothesized that GSK-
3β might be the mediating factor for Aldolase – a glyco-
lytic enzyme in its interaction with the degradation
complex. Our results support this hypothesis, providing
evidence of a physical interaction between GSK-3β and
each of the Aldolase isozymes. Assuming that Aldolase
activates the Wnt signaling pathway through an interaction
with the β-catenin degradation complex and particularly
GSK-3β, we speculated that neutralizing them would
diminish the effect induced by Aldolase. Indeed, trans-
fections of the human colon carcinoma cell line SW480,
in which the destruction complex is inactive, failed to
activate the Wnt cascade upon Aldolase overexpression.
Furthermore, Aldolase over-expression could not stabilize
the active form of β-catenin even when GSK-3β was spe-
cifically depleted using siRNA oligonucleotides. Together,
these findings suggest that Aldolase interacts and requires













Wnt signaling stimulation. (A) In the absence of Wnt stimulation,
rotein complex” (B) in cells that express high levels of the Aldolase
ex” is disassembled, disheveled and Axin re-localize to the membrane
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http://www.molecular-cancer.com/content/13/1/164expression of ALDOB or ALDOC altered the expression
pattern of Axin from cytoplasmic scattered punctate
expression to accumulation along the plasma membrane.
Similar changes in the expression pattern of Axin were
previously reported. Relocation of Axin from scattered
puncti to the cytoplasm was explained by a dynamic
exchange of Axin between punctuate and cytoplasmic
pools, leading to increased Wnt signaling [34,25,35]. Axin
interacts with the other components of the β-catenin deg-
radation complex, including GSK-3β, to create a scaffold
for their activity [36]. GSK-3β does not just bind Axin, but
also phosphorylates it to regulate its stability [37]. Hence,
we propose that the cytoplasmic complex formed between
Aldolase and GSK-3β, reduces the ability of the latter
to bind Axin Figure 6. Indeed, our findings suggest a
mechanism by which Aldolase may activate the Wnt
pathway by inhibiting the affinity of GSK-3β to Axin,
perhaps acting as a competitive inhibitor. This leads to
destabilization of the “β-catenin destruction complex”
and activation of β-catenin/TCF mediated transcription.
Under conditions in which the β-catenin degradation
complex is inactive, as in SW480 cells or upon depletion
of GSK-3β, Aldolase cannot interfere with the activity of
the complex and therefore cannot induce activation of
Wnt signaling. We speculate that the relocation of Axin
to the plasma membrane – which hinders the function of
the degradation complex as well – is secondary to the dis-
ruption of the GSK-3β-Axin interaction, as Aldolase activ-
ity is GSK-3β-dependent; this relocation may provide
further enhancement or stabilization of the primary effect
induced by Aldolase.
The Wnt signaling pathway is modified by various pro-
teins, some are known and others are yet to be revealed.
The presented work introduces the role of ALDOB and
ALDOC as positive regulators of the pathway characterizes
their relationship with components of the Wnt cascade and
proposes a mechanism for their action. As over-expression
of Aldolase induces Wnt signaling, Aldolase might act as a
colorectal oncogene, and therefore serve as a putative
therapeutic target for cancer treatment or diagnosis.
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where the effect of GFP, GFP-ALDOB and GFP-ALDOC over-expression on
different components of the Wnt cascade was measured. A representative blot
is shown in Figure 1C.
Additional file 2: Enzymatic activity of wild type and mutated
aldolases. HEK293T cells were transfected with the indicated plasmids
and subjected to immunoprecipitation using mouse anti-GFP antibody.
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Activity of the different aldolase isoforms compared to non-transfected
extracts. B. HEK293T cells lysates were harvested as described and subjected
to Western blot analysis to detect the transfected ALDO proteins. C. Purified
ALDX from rabbit muscle (Sigma) was used as positive control.Competing interests
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